The health tech and medtech investment landscape in the age of Covid-19
Fredrikson & Byron attorneys Ryan Johnson and Jeffrey Steinle share insights on how Covid-19 is continuing to transform the health tech and medtech landscape.
MedCity Spotlight Video: Fredrikson & Byron attorneys discuss Covid-19’s impact on deal-making and value-based care
In a Spotlight Video interview, Fredrikson & Byron Shareholders and Co-chairs of the firm's life sciences group, Jeff Steinle and Ryan Johnson, talked about the deal-making environment in healthcare and how the Covid-19 pandemic has impacted it.
As Healthcare and Biopharma Companies Embrace AI, Insurance Underwriters See Risks and Opportunities
In an interview, Munich Re Specialty Senior Vice President Jim Craig talked about the risk that accompanies innovation and the important role that insurers play.
The legal and regulatory landscape for digital health companies
Q&A with Fredrikson & Byron attorneys Ryan Johnson and Jeff Steinle